🕵️ Liminatus Pharma, Inc. ($LIMN)
SEC insider & ownership activity, last 12 months · CIK 1971387 · every row links its SEC filing
Insiders were quiet over the last 12 months – no open-market buys or sells. 5 red-flag 8-Ks in the window, most recently Delisting notice (3.01), Jul 20, 2026.
Insider flow
0 buyers, $0 (0 lots) · 0 sellers, $0 (0 lots)
No open-market insider transactions in the last 12 months.
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| IRIS Acquisition Holdings LLC | 26.5% | 13D | Apr 30, 2025 | filing ↗ | |
| KH Feelux Co., Ltd | 15.4% | 13G | Jun 27, 2025 | filing ↗ | |
| Valetudo Therapeutics LLC | 14.3% | 13D | Jul 2, 2026 | filing ↗ | |
| Chris Kim | 14.3% | 13D | Jul 2, 2026 | filing ↗ | |
| EWON Comfortech Co., Ltd. | 10.9% | 13G | Jul 6, 2026 | filing ↗ | |
| Red Peony Association 1ST | 5.7% | 13G | Jun 26, 2025 | filing ↗ | |
| Nongae Apple Association 1ST | 5.7% | 13G | Jun 26, 2025 | filing ↗ | |
| Samda Biolab Co., Ltd. | 5.1% | 13G | Jul 22, 2026 | filing ↗ |
Planned insider sales (Form 144)
No sale notices filed in the last 12 months.
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Delisting notice (3.01) | Jul 20, 2026 | filing ↗ |
| Other events (8.01) | Jul 20, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jul 20, 2026 | filing ↗ |
| Material agreement (1.01) | Jun 29, 2026 | filing ↗ |
| Acquisition or disposition (2.01) | Jun 29, 2026 | filing ↗ |
| Unregistered equity sale (3.02) | Jun 29, 2026 | filing ↗ |
| Charter/bylaw changes (5.03) | Jun 29, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jun 29, 2026 | filing ↗ |
| Material agreement (1.01) | Jun 3, 2026 | filing ↗ |
| Unregistered equity sale (3.02) | Jun 3, 2026 | filing ↗ |
| Material Modifications to Rights of Security Holders (3.03) | Jun 3, 2026 | filing ↗ |
| Other events (8.01) | Jun 3, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jun 3, 2026 | filing ↗ |
| Delisting notice (3.01) | May 20, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 20, 2026 | filing ↗ |
| Material agreement (1.01) | May 17, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 17, 2026 | filing ↗ |
| Charter/bylaw changes (5.03) | Feb 27, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Feb 27, 2026 | filing ↗ |
| Material agreement (1.01) | Feb 17, 2026 | filing ↗ |
| Other events (8.01) | Feb 17, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Feb 17, 2026 | filing ↗ |
| Material agreement (1.01) | Feb 6, 2026 | filing ↗ |
| Unregistered equity sale (3.02) | Feb 6, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Feb 6, 2026 | filing ↗ |
| Delisting notice (3.01) | Jan 15, 2026 | filing ↗ |
| Delisting notice (3.01) | Nov 19, 2025 | filing ↗ |
| Delisting notice (3.01) | Aug 22, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Aug 22, 2025 | filing ↗ |
| Reg FD disclosure (7.01) | Aug 14, 2025 | filing ↗ |